Loading...

SANA SANA BIOTECHNOLOGY INC Expansion Plans 8-K Filing

SN B

SN

SANA BIOTECHNOLOGY INC

(SANA)

2026 8-K

Board Restructure

Stock Sale Agreement

Financial Agreement Update

Executive Appointment

Corporate Presentation Update

Financial Results Announced

Management Change

Director Resignation

Equity Offerings

Clinical Updates

Product Expansion

Equity Offerings

Financial Results

Corporate Presentation

Financial Results

Management Changes

Management Change

Earnings Reports

Annual Meeting Results

Financial Results Announcement

Resignation of Executive

Financial Results Announcement

Public Offering

Financial Update

Conference Presentation

Financial Results Announcement

Portfolio Update and Workfo...

Regulation FD Disclosure

Termination of Lease Agreement

Financial Results Announcement

Annual Meeting Results

Presentation at Conference

Earnings Reports

Resignation of Executive

Management Changes

Financial Results Announcement

FDA Clearance for First-in-...

FDA Clearance for First-in-...

Regulation FD Disclosure

External Links:

Sana Biotechnology, Inc. announced its corporate presentation at the J.P. Morgan Healthcare Conference on January 14, 2026, providing updates on its programs, including promising results from its pancreatic islet cell therapy. Additionally, the company plans to file an investigational new drug application for a new therapy by year-end.

AI Assistant

SANA BIOTECHNOLOGY INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.